James W. McCollum is Director at LENZ Therapeutics, Inc. (LENZ). They have made 2 open-market trades across 1 company since 2024, most recently 2025-11-07.
CIK 0001200889
2 open-market purchases totalling $1.2M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LENZ | 10,500 | $34K |
Shares reported on the most recent Form 4, priced at the 2025-11-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.